
|Articles|October 1, 2003
FDA APPROVES CUBICIN
The FDA has approved Cubicin, a product of Cubist Pharmaceuticals that was formally called Cidecin, for treatment of complicated skin and structure infections caused by gram-positive bacteria.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Hilary Baldwin, MD, Highlights Emerging Acne and Rosacea Therapies at Elevate-Derm
2
Advancing Topical Stewardship and Expanding Nonsteroidal Options
3
Douglas DiRuggiero, PA-C, DMSc, Recognized at the Elevate-Derm Fall Conference
4
Education and Engagement Drive Momentum in Hair Disorders
5



















